DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the PE ratio of Tyche Industries Ltd?

Tyche Industries Ltd has a price-to-earnings (PE) ratio of 18.9 in the Healthcare sector.

What is the market capitalisation of Tyche Industries Ltd?

Tyche Industries Ltd has a market capitalisation of approximately ₹131 crore.

Tyche Industries Ltd

532384·NSE·Healthcare

₹0.00▲ +0.00 (+0.00%)

Mkt Cap₹131 Cr

P/E18.90

Vol—

Day—

52W99–148

Trading suspended. Not a live price.

Healthcare · Pharmaceuticals

A steady, established business

O—H—L—PC—VWAP—VOL—

52W₹99.00

₹148.00

Snapshot

Key stats

Mkt Cap

₹131 Cr

P/E

18.90Fair

P/B

0.93

ROE

5.01%Weak

ROCE

12.67%Decent

52W High / Low

₹148 / ₹99

Div Yield

2.35%

EPS

₹12.11

Free — see our deterministic Fair Value range, business quality score, and the full bull/bear case for this stock.

Snapshot

Key statistics

P/E

18.9Fair

Below 15× is value territory; above 35× prices in strong growth

ROE

5.0%Weak

Above 15% is considered healthy for Indian equities

ROCE

12.7%Decent

Above 18% means capital is working hard

Debt/Eq

0.00Low

Below 0.5 is comfortable; above 1.5 strains the balance sheet

Mkt Cap

₹131 Cr

P/B

0.93

EPS

₹12.11

Div Yield

2.35%

What changed

Recent changes

No notable changes to report.

What matters

News impact

Today

Trading activity

Delivery %—

Turnover—

Trades—

VWAP—

Face value₹10.00

Market depth

Market depth available during market hours

Snapshot

Technical signals

Compounded annual growth

Growth (CAGR)

Revenue

-10.7%

-7.3%

10Y

-0.1%

Profit

-21.4%

-19.2%

10Y

+10.8%

EPS

-4.7%

-9.3%

10Y

+17.4%

Profile

Pros

Company is almost debt free.
Stock is trading at 0.92 times its book value
Company has been maintaining a healthy dividend payout of 32.5%

Watch-outs

Cons

The company has delivered a poor sales growth of -7.28% over past five years.
Company has a low return on equity of 8.05% over last 3 years.
Earnings include an other income of Rs.9.22 Cr.
Debtor days have increased from 110 to 133 days.

More Healthcare stocks · Pharmaceuticals

Explore Tyche Industries Ltd’s valuation

Free deep-dive tools · no sign-up

Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.